Publication | Closed Access

Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study

Metastatic SitesHigh Pd-l1 ExpressionMedicineImmunologyPathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung Cancer